Home / Lab Basics / Consultation prep

Lab basics

How to prepare for a peptide consultation: what to bring, what to ask

Before the visit

A good peptide consultation is not a quiz. It is a conversation, and like most conversations, it goes better when both sides come prepared.

Readers often show up to these visits anxious, partially informed from a mix of sources, and unsure what the clinician is allowed to discuss. The anxiety is usually driven by the sense that the clinician will either dismiss the question or rubber-stamp it, with no middle ground. In practice, the thoughtful middle ground is almost always available. You just have to make the conversation easy for the clinician to join.

Two hours of preparation before a thirty-minute visit is a reasonable ratio. Not because the visit is difficult, but because it is short, and the clinician is working with whatever you put in front of them.

What to write down before the appointment

I bring a single printed page. One side, seven sections. A clinician can scan it in 45 seconds, and it anchors the conversation in specifics rather than vibes.

1. Why I am here. One sentence. Not “I want to try a peptide.” Instead: “I have been dealing with X, I have tried Y, and I want to understand whether a peptide conversation is warranted.” The distinction between “I want” and “I want to understand” is not cosmetic. It tells the clinician what role they are being asked to play.
2. The specific goal. What exactly are you trying to change. Body composition, recovery from a specific condition, a measurable lab value, a quality-of-life issue. The more specific the goal, the more specific the conversation can be.
3. What I have already tried. Diet changes, exercise programs, sleep interventions, prior conversations with other clinicians, any relevant medication history. Nothing makes a clinician more useful than knowing you have already done the obvious things.
4. Current medications. Every prescription, every over-the-counter medication, every supplement you take regularly. Yes, even fish oil. Interactions are a real part of the conversation and the clinician needs the full picture.
5. Relevant medical history. Anything on your personal history or your immediate family history that could matter. Cancer history. Cardiovascular history. Endocrine history. Diabetes. The clinician will ask anyway; saving them time means more time for the actual conversation.
6. Peptide(s) I am curious about and why. Name the specific compound(s). Be honest about where you heard about them. “A podcast” is a perfectly good answer. The clinician is not judging you for how you got to the question; they are trying to calibrate how well-founded the interest is.
7. Questions I want answered. Three to six. Written down. The last section of this article is a good starting point for those.

Questions to ask, specific to your peptide of interest

These are the questions worth asking regardless of the specific compound on the table. If the conversation is about a particular peptide, I would add a couple of compound-specific questions (see the monograph for the one you are researching; each includes a tailored list).

1. Based on what I have written down, is the peptide I am asking about even a plausible conversation, or is there something else you would recommend addressing first?
2. What does the human evidence for this compound actually look like, in your reading? Are there RCTs, observational studies, or only animal data?
3. If we proceed, what bloodwork baseline would you want before starting, and what would you want to recheck after a defined interval?
4. What is your own comfort level with compounded peptides in this class, and how many patients have you actively worked with on this kind of conversation?
5. If I obtain a preparation through a 503A pharmacy, what documentation do you want to see (prescription fulfillment, certificate of analysis)?
6. What would make you want to pause, adjust, or stop the conversation after we start? What signs would you want me to flag between visits?

Reading the clinician on the other side

A thoughtful clinician does not handle a peptide question with either eagerness or dismissal. They treat it as a conversation about a category of compound where evidence is heterogeneous, regulatory posture is active, and patient risk is real. That posture is visible.

Signs you are talking to a clinician worth working with:

• They ask about your baseline before they talk about any specific compound.
• They distinguish between human evidence and non-human evidence without being prompted.
• They have a view on the 503A framework and can articulate why some peptides sit outside it.
• They can say “I am not comfortable with that compound” about some specific peptides and “I can work with that” about others, and they can explain the difference.
• They describe monitoring, not just initiation. A clinician who has a view on how to follow up is a clinician who has done this before.

How 503A telehealth consultations typically work

Most compounded peptide conversations in the US today happen through telehealth clinics that work with licensed 503A pharmacies. The structural pattern is:

1. An intake form covering your medical history, goals, and current medications. Some clinics require bloodwork before the first visit.
2. A video or phone consultation with a licensed clinician (MD, DO, NP, or PA, depending on state scope-of-practice rules).
3. If the clinician writes a prescription, the prescription is sent to a partner 503A pharmacy, which fills it and ships the preparation directly to you.
4. Follow-up visits at defined intervals, usually with updated bloodwork, for any ongoing preparation.

The telehealth model is not inherently worse than in-person care, but the quality of individual operations varies enormously. The questions from the previous section apply to a telehealth clinic the same way they apply to a local clinician. A reputable telehealth clinic has no problem answering them. An operation more interested in throughput will dodge some of them.

One additional consideration: confirm the 503A pharmacy the clinic dispenses through. Ask for the pharmacy name. Verify the state license the way the 503A framework article walks through. If the clinic is unwilling to name the pharmacy, that is already an answer.

What to expect in terms of follow-up monitoring

For any peptide conversation that proceeds past the initial visit, follow-up monitoring is the core of ongoing care. What this usually looks like:

• A follow-up visit within 4 to 12 weeks of starting any prescribed preparation, to check in on subjective response, any side effects, and whether early lab trends are moving as expected.
• Repeat bloodwork at defined intervals, typically matching the baseline panels so that the comparison is direct.
• Ongoing visits every 3 to 6 months for any continued preparation, with lab monitoring timed to the visit.
• An explicit stopping criterion discussed at the start, not invented later. The question “what would make us stop this” is asked before the first preparation arrives, not after something goes wrong.

If a clinic proposes a plan with no follow-up, declines to repeat bloodwork, or does not have a view on what would make them stop, the plan is incomplete. That is not a judgment call about that particular clinic; it is a pattern recognition across the category.

Red flags in a clinician or clinic

These are the patterns that mean you are not in a clinical conversation, even if the intake form and the white coat suggest otherwise.

A clinician who ends the conversation with “not right now, because X” is doing their job. That is not a failed consultation. That is a good one.

What to do next

Sources

• American Medical Association. Guidance on telehealth consultations and informed consent.
• Federation of State Medical Boards. Telehealth policy and scope-of-practice references.
• FDA. Section 503A compounding framework and prescriber-pharmacy relationship.
• Agency for Healthcare Research and Quality (AHRQ). Patient-clinician communication guidance and pre-visit preparation materials.
• Pharmacy Compounding Accreditation Board (PCAB). Accreditation directory and standards.

References are general. No specific telehealth clinic, pharmacy, or practitioner is named anywhere on this site.

Related reading